TITLE

DEVELOPMENTS IN LIVER TRANSPLANTATION

AUTHOR(S)
Neuberger, J.
PUB. DATE
May 2004
SOURCE
Gut;May2004, Vol. 53 Issue 5, p759
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the developments in liver transplantation. An increasing number of immunosuppressive agents are being introduced into clinical practice which provides the clinician with exciting oppurtunities to tailor immunosuppression for the individual. There are many new drugs introduced like Mycophenolate mofetil, Calcineurin inhibitors, Sirolimus and everolimus. Most medical centres are using mycophenolate in place of azathioprine. Increasingly, centres are withdrawing corticosteroids during the first postoperative year. INSETS: Box 1 Alcoholic liver disease.;Box 2 Characteristics of HCV reinfection.;Box 3 Issues surrounding HIV and liver transplantation (from....
ACCESSION #
13148314

 

Related Articles

  • Pharmacokinetics of Mycophenolic Acid and Determination of Area Under the Curve by Abbreviated Sampling Strategy in Chinese Liver Transplant Recipients. Hao Chen; Chenghong Peng; Zhicheng Yu; Baiyong Shen; Xiaxing Deng; Weihua Qiu; Yue Fei; Chuan Shen; Guangwen Zhou; Weiping Yang; Hongwei Li // Clinical Pharmacokinetics;2007, Vol. 46 Issue 2, p175 

    Objectives: This study aimed to: (i) define the clinical pharmacokinetics of mycophenolic acid (MPA) in Chinese liver transplant recipients; and (ii) develop a regression model best fitted for the prediction of MPA area under the plasma concentration-time curve from 0 to 12 hours (AUC12) by...

  • Azathioprine/prednisone/tacrolimus.  // Reactions Weekly;1/26/2008, Issue 1186, p12 

    The article describes the case of a 39-year-old man who developed a cutaneous usAspergillus tus infection while receiving azathioprine, prednisone and tacrolimus. The man, who had undergone single-lung transplantation previously, developed bilateral lower extremity oedema and black spots on his...

  • Ciclosporin interaction.  // Reactions Weekly;4/3/2004, Issue 995, p7 

    Discusses research being done on a female liver transplant recipient who experienced a decrease in ciclosporin trough concentrations after treatment with sevelamer that was started for persistent hyperphosphataemia during haemodialysis. Reference to a study by M. Jadoul et al, published in the...

  • Calcineurin Inhibitor Sparing in Paediatric Solid Organ Transplantation: Managing the Efficacy/Toxicity Conundrum. Tredger, J Michael; Brown, Nigel W; Dhawan, Anil // Drugs;2008, Vol. 68 Issue 10, p1385 

    Despite their efficacy, the calcineurin inhibitors (CNIs) ciclosporin and tacrolimus carry a risk of debilitating adverse effects, especially nephrotoxicity, that affect the long-term outcome and survival of children who are given organ transplants. Simple reduction in dosage of CNI has little...

  • Chronopharmacokinetics of Ciclosporin and Tacrolimus. Baraldo, Massimo; Furlanut, Mario // Clinical Pharmacokinetics;2006, Vol. 45 Issue 8, p775 

    The correct use of immunosuppressive drugs has a considerable influence on the prognosis of patients with organ transplants. The appropriate utilisation of the drugs involves the administration of an adequate dosage to reach the blood concentrations that will suppress the alloimmune response,...

  • Ciclosporin.  // Reactions Weekly;3/7/2009, Issue 1242, p15 

    The article describes the case of a male renal transplant recipient who developed an acute phosphate nephropathy during immunosuppressive treatment with ciclosporin. The patient had an end-stage renal disease and subtotal parathyroidectomy and underwent renal transplantation. He later developed...

  • Immunosuppressants.  // Reactions Weekly;1/12/2008, Issue 1184, p23 

    The article describes the case of two liver transplant recipients who developed tuberculosis infection while receiving immunosuppressive therapy. Patient 1, a 32-year-old man, developed tuberculosis infection during treatment with ciclosporin, methylprednisolone and mycophenolate mofetil....

  • CURRENT BIOCHEMICAL MONITORING AND RISK MANAGEMENT OF IMMUNOSUPPRESSIVE THERAPY AFTER TRANSPLANTATION. Catić-Đorđević, Aleksandra; Cvetković, Tatjana; Stefanović, Nikola; Veličković-Radovanović, Radmila // Journal of Medical Biochemistry;Jan2017, Vol. 36 Issue 1, p1 

    Immunosuppressive drugs play a crucial role in the inhibition of immune reaction and prevention of graft rejection as well as in the pharmacotherapy of autoimmune disorders. Effective immunosuppression should provide an adequate safety profile and improve treatment outcomes and the patients'...

  • THE EFFECT OF ANTILYMPHOCYTE SERUM (ALS) ON THE SECONDARY IMMUNE RESPONSE IN MICE. Marshall, V. R.; Knight, P. R. // Australian Journal of Experimental Biology & Medical Science;Apr1969, Vol. 47 Issue 2, p275 

    The article informs that Antilymphocyte serum (ALS) has been shown to prolong the survival of skin allografts and skin xenografts in experimental animals. The search for better immunosuppressive agents to prolong the survival of human renal allograft's led to assess its value in a series of 20...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics